Nearly a third of families with children receiving chemotherapy for acute lymphoblastic leukemia (ALL) – the most common pediatric cancer – develop serious financial difficulties during their child’s treatment, including losing 25% or more of their household income and struggling to cover the costs of basic living expenses such as housing, food, and utilities.

An interdisciplinary team of researchers at the University of California, Santa Cruz, has published a new study using transaction data provided by Zillow to show that homebuyers price in the natural-defense value of mangrove after heavy storm seasons. The new research, published in the journal Review of Finance, finds that homes in coastal Florida saw smaller price declines after storms when they were near mangrove forests versus homes that were farther from them.

OYE Therapeutics Inc., a privately held biopharmaceutical company, has announced the successful close of its $5 million convertible note financing, positioning the company to enter clinical development. Proceeds from the raise will support OYE’s Phase 1 pharmacokinetic and safety study and its subsequent pivotal trials. The company develops first-in-class intravenous caffeine-based therapies for anesthesia recovery and opioid-induced respiratory depression.

In a new study, Francisco Polidoro Jr., professor of management at Texas McCombs, finds present-day insights in an old innovation story: how NASA developed its space shuttles, which flew from 1981 to 2011. The lessons can inform today's rocketeers and anyone looking for breakthroughs cutting-edge fields, from phones to pharmaceuticals.

Rather than a straightforward sequence, NASA used a meandering knowledge-building process, he finds. That process allowed it to systematically explore rocket features, both individually and together.

“With breakthrough inventions, the number of combinations of possible features quickly explodes, and you just can’t test all of them,” Polidoro says. “It has to be a much more selective search process.”